- Home
- REPL vs GOOD Comparison
REPL vs GOOD Comparison
Compare REPL & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- GOOD
- Stock Information
- Founded
- REPL 2015
- GOOD 2003
- Country
- REPL United States
- GOOD United States
- Employees
- REPL N/A
- GOOD N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- GOOD Real Estate Investment Trusts
- Sector
- REPL Health Care
- GOOD Real Estate
- Exchange
- REPL Nasdaq
- GOOD Nasdaq
- Market Cap
- REPL 547.0M
- GOOD 534.5M
- IPO Year
- REPL 2018
- GOOD N/A
- Fundamental
- Price
- REPL $10.07
- GOOD $11.29
- Analyst Decision
- REPL Buy
- GOOD
- Analyst Count
- REPL 9
- GOOD 0
- Target Price
- REPL $10.88
- GOOD N/A
- AVG Volume (30 Days)
- REPL 8.8M
- GOOD 522.5K
- Earning Date
- REPL 11-07-2025
- GOOD 11-03-2025
- Dividend Yield
- REPL N/A
- GOOD 10.72%
- EPS Growth
- REPL N/A
- GOOD N/A
- EPS
- REPL N/A
- GOOD 0.36
- Revenue
- REPL N/A
- GOOD $153,643,000.00
- Revenue This Year
- REPL N/A
- GOOD $7.51
- Revenue Next Year
- REPL N/A
- GOOD $4.39
- P/E Ratio
- REPL N/A
- GOOD $31.42
- Revenue Growth
- REPL N/A
- GOOD 5.85
- 52 Week Low
- REPL $2.68
- GOOD $11.13
- 52 Week High
- REPL $17.00
- GOOD $17.88
- Technical
- Relative Strength Index (RSI)
- REPL 75.32
- GOOD 30.93
- Support Level
- REPL $7.69
- GOOD $11.13
- Resistance Level
- REPL $10.85
- GOOD $11.52
- Average True Range (ATR)
- REPL 0.67
- GOOD 0.21
- MACD
- REPL 0.48
- GOOD 0.03
- Stochastic Oscillator
- REPL 88.10
- GOOD 24.09
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.